These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 6735340)

  • 1. [Higher therapeutic safety of Mono-Nitrate. Report on the 3rd Mono-Nitrate Workshop of the Pharma-Schwarz Company, Monheim].
    Fortschr Med; 1984 May; 102(20):70-1. PubMed ID: 6735340
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effectiveness of the delayed-action form of isosorbide 5-mononitrate in ischemic heart disease].
    Hůla J; Trhlíková M
    Vnitr Lek; 1991 Mar; 37(3):248-54. PubMed ID: 2031313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of 50 mg isosorbide-5-nitrate retard on the stress tolerance of patients with coronary heart disease].
    Eggeling T; Jansen W; Osterspey A; Tauchert M; Hilger HH
    Med Klin (Munich); 1986 Apr; 81(8):275-80. PubMed ID: 3785087
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapeutic effectiveness of isosorbide-5-mono nitrate in the treatment of exertion myocardial ischemia].
    Cassottana P; Torre F; Bafico GL; Oddone D; Vinci P; Gatto R; Borgo E
    Minerva Cardioangiol; 1987; 35(1-2):79-82. PubMed ID: 3561813
    [No Abstract]   [Full Text] [Related]  

  • 5. [Long-term tolerance and effect of isosorbide-5-mononitrate in comparison to isosorbide dinitrate (ISDN retard) in patients with coronary disease].
    Smolarz A; Seeliger S; Glocke M
    Med Welt; 1981 Apr; 32(14A):548-53. PubMed ID: 6787385
    [No Abstract]   [Full Text] [Related]  

  • 6. [The effect of IS-5-MN in coronary disease. Monocentric double-blind crossover comparison with ISDN retard and placebo].
    Müller G; Schmidt-Voigt J
    Med Welt; 1981 Apr; 32(14A):554-6. PubMed ID: 7242319
    [No Abstract]   [Full Text] [Related]  

  • 7. [Slow-release nitrates: a critical review].
    Ambrosioni E; Strocchi E
    Cardiologia; 1987 Nov; 32(11):1283-6. PubMed ID: 3129193
    [No Abstract]   [Full Text] [Related]  

  • 8. Can the problem of nitrate tolerance be solved?
    Silber S
    Z Kardiol; 1985; 74 Suppl 1():51-4. PubMed ID: 3993162
    [No Abstract]   [Full Text] [Related]  

  • 9. [Isosorbide mononitrate or dinitrate in coronary disease?].
    Schanzenbächer P; Kochsiek K
    Dtsch Med Wochenschr; 1983 May; 108(21):807-9. PubMed ID: 6851870
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of isosorbide-5-mononitrate, metipranolol and a combination of the two in experimental myocardial ischemia in the awake dog].
    Sponer G; Voss E; Dietmann K
    Med Welt; 1981 Apr; 32(14A):492-6. PubMed ID: 6113532
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparison of the anti-angina effect and effect duration of isosorbide dinitrate, isosorbide-2-mononitrate (IS-2-MN) and isosorbide-5-mononitrate (IS-5-MN)].
    Reifart N; Reifart F; Kaltenbach M; Bussmann WD
    Med Welt; 1981 Apr; 32(14A):524-6. PubMed ID: 7242313
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative clinical evaluation of ISDN and 5-ISMN as exemplified by Mono Mack 20 mg/40 mg].
    Schmidt G
    Med Welt; 1983 Jun; 34(25-26):732-3. PubMed ID: 6888243
    [No Abstract]   [Full Text] [Related]  

  • 13. Electrocardiographic analysis of the effects of isosorbide-5-mononitrate on regional myocardial ischemia in conscious dogs.
    Strein K; Sponer G; Bartsch W; Müller-Beckmann B; Dietmann K
    J Pharmacol Exp Ther; 1984 Jun; 229(3):787-92. PubMed ID: 6726657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is isosorbide mononitrate better than the dinitrate?
    Drug Ther Bull; 1984 Jan; 22(2):7-8. PubMed ID: 6363029
    [No Abstract]   [Full Text] [Related]  

  • 15. [Steady state kinetics of isosorbide-5-mononitrate in patients with coronary disease].
    Mannebach H; Ohlmeier H; von Möllendorff E; Gleichmann U; Abshagen U
    Med Welt; 1981 Apr; 32(14A):517-20. PubMed ID: 7242311
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effects of isosorbide dinitrate of prolonged action on the prevention of myocardial ischemia induced by exercise: correlation with nitrate blood levels].
    Duprat R; Meneghelo RS; Batlouni M; Hoxter G
    Arq Bras Cardiol; 1975 Jun; 28(3):369-77. PubMed ID: 1180718
    [No Abstract]   [Full Text] [Related]  

  • 17. [Long-term effect of a new delayed-action nitroglycerin compared to isosorbide dinitrate. Double-blind hemodynamic study].
    Witt E; Lehmann HU; Traue P; Hochrein H
    Dtsch Med Wochenschr; 1983 Feb; 108(6):216-20. PubMed ID: 6402355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term tolerance and therapeutic coronary effect of isosorbide-5-mononitrate. Open multicenter study of ISMO 20].
    Uberbacher HJ; Glocke M; Abshagen U
    MMW Munch Med Wochenschr; 1983 Jan; 125(4):76-8. PubMed ID: 6402686
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of isonit (nitrosorbide) in the treatment of ischemic heart disease].
    Zamotaev IP; Venediktova MG; Lozinskiĭ LG; Sandomirskiĭ BL
    Klin Med (Mosk); 1986 Jun; 64(6):28-33. PubMed ID: 3747432
    [No Abstract]   [Full Text] [Related]  

  • 20. [Value of Iso Mack Retard in the treatment of coronary disease].
    Zminkowska U; Markiewicz M
    Wiad Lek; 1984 Apr; 37(7):496-500. PubMed ID: 6385487
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.